Solventum Corp (SOLV) financials

Solventum Corp (SOLV) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Solventum Corp reported revenue of $8.32B, up 0.9% year over year, net income of $1.56B, diluted EPS of $8.88 and free cash flow of -$10M.

Revenue (fiscal 2025)

$8.32B

Revenue growth (fiscal 2025)

0.9%

Net income (fiscal 2025)

$1.56B

Diluted EPS (fiscal 2025)

$8.88

Free cash flow (fiscal 2025)

-$10M

Solventum Corp files with the U.S. Securities and Exchange Commission under CIK 0001964738, classified as Surgical & Medical Instruments & Apparatus.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.